SG11201908183YA - Skin barrier composition - Google Patents
Skin barrier compositionInfo
- Publication number
- SG11201908183YA SG11201908183YA SG11201908183YA SG11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA SG 11201908183Y A SG11201908183Y A SG 11201908183YA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- skin
- floor
- pct
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1707489.9A GB2562270B (en) | 2017-05-10 | 2017-05-10 | Skin barrier composition |
PCT/GB2018/051262 WO2018206962A1 (en) | 2017-05-10 | 2018-05-10 | Skin barrier composition |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201908183YA true SG11201908183YA (en) | 2019-10-30 |
Family
ID=59065602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201908183Y SG11201908183YA (en) | 2017-05-10 | 2018-05-10 | Skin barrier composition |
Country Status (11)
Country | Link |
---|---|
US (2) | US11173172B2 (ja) |
EP (1) | EP3621653A1 (ja) |
JP (1) | JP7228531B2 (ja) |
KR (1) | KR102646319B1 (ja) |
CN (1) | CN110621346B (ja) |
AU (1) | AU2018267267B2 (ja) |
GB (1) | GB2562270B (ja) |
MY (1) | MY189248A (ja) |
PH (1) | PH12019502062A1 (ja) |
SG (1) | SG11201908183YA (ja) |
WO (1) | WO2018206962A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3641725A1 (en) | 2017-06-23 | 2020-04-29 | The Procter and Gamble Company | Composition and method for improving the appearance of skin |
EP3817717A1 (en) | 2018-07-03 | 2021-05-12 | The Procter & Gamble Company | Method of treating a skin condition |
JP2023528616A (ja) | 2020-06-01 | 2023-07-05 | ザ プロクター アンド ギャンブル カンパニー | ビタミンb3化合物の皮膚への浸透を改善する方法 |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
GB2596286B (en) * | 2020-06-20 | 2023-01-25 | Francis Davis Adrian | Adherence to topical therapy |
US20220192961A1 (en) * | 2020-12-17 | 2022-06-23 | L'oreal | Hydroglycolic cosmetic composition with a high active content |
GB2616294A (en) * | 2022-03-03 | 2023-09-06 | Hyphens Pharma Pte Ltd | Composition for use |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954487A (en) * | 1979-01-08 | 1990-09-04 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
US5385938B1 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of using glycolic acid for treating wrinkles |
DE69328682T2 (de) * | 1992-06-19 | 2000-12-28 | Univ California | Lipide zur epidermalen Befeuchtung und zur Wiederherstellung der Barrierefunktion |
DK0752843T3 (da) * | 1994-03-29 | 2001-03-19 | Procter & Gamble | Sammensætninger til kunstig solbrændthed, som har forbedret farveudvikling |
US5618850A (en) * | 1995-03-09 | 1997-04-08 | Focal, Inc. | Hydroxy-acid cosmetics |
DE19719856A1 (de) * | 1997-05-12 | 1998-11-19 | Henkel Kgaa | Hautpflegemittel |
US6335023B1 (en) * | 1999-06-30 | 2002-01-01 | Ruey J. Yu | Oligosaccharide aldonic acids and their topical use |
JP3713406B2 (ja) | 1999-07-16 | 2005-11-09 | 株式会社資生堂 | 皮膚外用ゲル製剤 |
US20020119174A1 (en) * | 2000-07-26 | 2002-08-29 | Gardlik John Michael | Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates |
US20020035070A1 (en) * | 2000-07-26 | 2002-03-21 | The Procter & Gamble Company | Method of regulating hair growth using metal complexes of oxidized carbohydrates |
EP1324737A2 (en) * | 2000-10-10 | 2003-07-09 | The Procter & Gamble Company | Packaged scalp cosmetic compositions |
EP1670433B1 (en) | 2003-10-10 | 2011-11-23 | Antares Pharma IPL AG | Transdermal pharmaceutical formulation for minimizing skin residues |
CA2595023A1 (en) | 2005-01-19 | 2006-07-27 | Children's Hospital Medical Center | Simulated vernix compositions for skin cleansing and other applications |
WO2006081071A1 (en) | 2005-01-26 | 2006-08-03 | The Procter & Gamble Company | Low ph skin care compositions containing dehydroacetic acid |
GB0617191D0 (en) | 2006-08-31 | 2006-10-11 | York Pharma Plc | Improvements in pharmaceutical compositions |
JP5578869B2 (ja) | 2010-01-27 | 2014-08-27 | ユニチカ株式会社 | 角質層ターンオーバー促進剤 |
KR101773095B1 (ko) | 2010-11-30 | 2017-08-31 | (주)아모레퍼시픽 | 저점도의 비분리형 자외선차단제 조성물 |
JP2013060393A (ja) | 2011-09-13 | 2013-04-04 | Nitto Denko Corp | 経皮吸収促進用組成物および貼付製剤 |
US9636376B2 (en) * | 2012-09-11 | 2017-05-02 | Innopharma, Inc. | Stable compositions of peptide epoxy ketones |
JP6151935B2 (ja) | 2013-03-11 | 2017-06-21 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
US20150024074A1 (en) * | 2013-07-22 | 2015-01-22 | Johnson & Johnson Consumer Companies Inc. | Methods for treating skin barrier and reducing acne |
JP2014114291A (ja) * | 2013-12-13 | 2014-06-26 | Showa Denko Kk | 化粧料または皮膚外用剤 |
KR20160026042A (ko) | 2014-08-29 | 2016-03-09 | (주)아모레퍼시픽 | 락토비온산을 함유하는 항스트레스용 또는 항상성 유지용 조성물 |
CN105434213A (zh) * | 2015-08-04 | 2016-03-30 | 马南行 | 一种舒缓皮肤的美容组合物及其制备方法 |
-
2017
- 2017-05-10 GB GB1707489.9A patent/GB2562270B/en active Active
-
2018
- 2018-05-10 EP EP18725608.6A patent/EP3621653A1/en active Pending
- 2018-05-10 MY MYPI2019005711A patent/MY189248A/en unknown
- 2018-05-10 JP JP2019562640A patent/JP7228531B2/ja active Active
- 2018-05-10 US US16/611,529 patent/US11173172B2/en active Active
- 2018-05-10 CN CN201880031234.9A patent/CN110621346B/zh active Active
- 2018-05-10 WO PCT/GB2018/051262 patent/WO2018206962A1/en active Search and Examination
- 2018-05-10 KR KR1020197028922A patent/KR102646319B1/ko active IP Right Grant
- 2018-05-10 SG SG11201908183Y patent/SG11201908183YA/en unknown
- 2018-05-10 AU AU2018267267A patent/AU2018267267B2/en active Active
-
2019
- 2019-09-11 PH PH12019502062A patent/PH12019502062A1/en unknown
-
2021
- 2021-10-13 US US17/500,604 patent/US11890294B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR102646319B1 (ko) | 2024-03-11 |
KR20190142324A (ko) | 2019-12-26 |
US11890294B2 (en) | 2024-02-06 |
US11173172B2 (en) | 2021-11-16 |
EP3621653A1 (en) | 2020-03-18 |
AU2018267267B2 (en) | 2023-09-07 |
CN110621346A (zh) | 2019-12-27 |
US20200222438A1 (en) | 2020-07-16 |
JP2020519649A (ja) | 2020-07-02 |
CN110621346B (zh) | 2024-04-12 |
GB201707489D0 (en) | 2017-06-21 |
WO2018206962A1 (en) | 2018-11-15 |
GB2562270B (en) | 2020-07-01 |
GB2562270A (en) | 2018-11-14 |
PH12019502062A1 (en) | 2020-07-06 |
US20220031721A1 (en) | 2022-02-03 |
AU2018267267A1 (en) | 2019-10-10 |
JP7228531B2 (ja) | 2023-02-24 |
MY189248A (en) | 2022-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201908183YA (en) | Skin barrier composition | |
SG11201803920TA (en) | Compounds and compositions useful for treating disorders related to ntrk | |
SG11201906891RA (en) | Methods for the administration of certain vmat2 inhibitors | |
SG11201903938XA (en) | Acylated glp-1/glp-2 dual agonists | |
SG11201811149TA (en) | METABOLIC DRUG LOADING OF EVs | |
SG11201811150WA (en) | Ev-mediated delivery of binding protein-small molecule conjugates | |
SG11201811148SA (en) | Cell penetrating peptide (cpp)-mediated ev loading | |
SG11201808682XA (en) | Silicone atoms containing ivacaftor analogues | |
SG11201900163PA (en) | Macrocycle kinase inhibitors | |
SG11201806583XA (en) | Compositions containing tucaresol or its analogs | |
SG11201407397WA (en) | Formulations and methods for vaginal delivery of antiprogestins | |
SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
SG11201901070YA (en) | Formulations for oral administration of active agents | |
SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
SG11201811351WA (en) | Compositions and methods for forming stable, liquid metal oxide/hydroxide formulations | |
SG11201909735YA (en) | Therapeutic compounds and compositions, and methods of use thereof | |
SG11201809976PA (en) | Protection of plant extracts and compounds from degradation | |
SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
SG11201908114UA (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
SG11201910206QA (en) | Methods and compositions for treating inflammatory gastrointestinal disorders | |
SG11201805149XA (en) | Compositions comprising 15-hepe and methods of using the same | |
SG11201808650QA (en) | Methods of treating ocular conditions | |
SG11201909478UA (en) | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication | |
SG11201810403VA (en) | Drug-delivery nanoparticles and treatments for drug-resistant cancer | |
SG11201909016TA (en) | Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety |